All posts by wp_3575070

2021 activities

November 25: Through the kind advice of Dr. Murat Gultekin, the Secretary-General gives e speech at The Bulgarian National Cancer Control Plan organized by the Bulgarian Natl Assembly of Health Care: Mission Possible: Abstract:

The role of Family Doctors in Cancer Control. An underexploited resource to be urgently reprogrammed.  Pier Giorgio Natali MD, Ph.D. Mediterranean Taskforce for Cancer Control (MTCC),(www.mtcc-prevention.net)

Introduction: Because of increasing life expectancy, cancer represents a global emergency that can be tackled only by policies aimed at ensuring to the largest population a continuum of primary prevention interventions, access to early diagnosis, and therapies.

Description: A large fraction of cancers are already avoidable by primary prevention, the remaining averted by early diagnosis, thus limiting the occurrence of advanced disease “the key challenge in cancer treatment”.

Results: The presence of Family Doctors (FDs) on the territory has steadily declined in many public-private and mixed health systems due to policies that have moved health care from the territory to the hospital. This is in contrast to long-standing recognition of the link between life expectancy and density of FDs. The limits of this “hospital-focussed” architecture are now dramatically underscored by the occurring Covid pandemic. Collectively, this organizational drift requires interventions that cannot be further postponed in terms of reprogramming the “territorial oncology”. Thus any political inertia not fully exploiting the available knowledge to reduce the incidence of advanced diseases is unjustified from medical, ethical, and social points of view and is necessarily fostering an increase in unsustainable costs even for wealthy societies. In this context, FDs can play a major role in cancer control because a) can provide reliable censored information,  thus contributing to increase health literacy and advocacy b) know the patient’s history, living- occupational environment, thus being able to perceive symptoms that patient may underestimate c) can enforce preventive and diagnostic procedures tailored to patient’s co-morbidities d) cure chronic diseases often heralding tumor onset e) ensure referring specialists according to criteria of priority and congruity.

Take home message: FDs have an important and expanding role in cancer control that often goes beyond screening and diagnosis to treatment, survivorship, and palliative care. On the whole, family medicine is a privileged reference for health policymakers being the source of information on the feasibility, effectiveness, and economic sustainability of the adopted policies also in view of the increasing disparities.

November 24-26: Dr. Maisan Akroush organizes in Amman the Jordan Women Doctor Conference; excellence, distinction, and leadership

Jowomenconference@gmail.com

https://drive.google.com/file/d/1lok4kVUUWzQA4zCvNVEL4AocmQ6lc3nA/view

November: MTCC and The Italian League Against Cancer, Rome Chapter (LILT-Rome) post on the LILT Rome website the guidelines for Cancer Prevention for the LGBT+ Communities

October: our Members Maisam Akroush and Ziad Sharaiha endorse the Breast Cancer Prevention Campaign in Jordan

September. see June MTCC is chairing a session at the
XI PROBIOTICS, PREBIOTICS NEW FOODS, NUTRACEUTICALS, AND BOTANICALS for NUTRITION & HUMAN and MICROBIOTA HEALTH Rome Sept 12-14

Sept,25th. As MTCC Secretary-General Dr. Natali is lecturing at the 2021 Congress of the European Society for Translational Medicine (EUSTM). The role of General Practitioners in Cancer Control. An underexploited resource in translational oncology.

June: MTCC  signed a collaboration agreement with LILT for the development of public awareness messages

April: MTCC endorses the coming  XI PROBIOTICS, PREBIOTICS NEW FOODS, NUTRACEUTICALS, AND BOTANICALS for NUTRITION & HUMAN and MICROBIOTA HEALTH Rome Sept 12-14 (Organizer Prof Lucio Capurso, MTCC Member). In a Session dedicated to our beloved Members,  Massimo Crespi and Alberto Montori, three MTCC Members (Natali, Saggioro, Ascione) will give presentations to the section. Our Member   N. Lahbabi-Amrani President WGO (World Gastroenterology Organization) will contribute to the opening ceremony with a presentation titled “WGO activities and its involvement in nutrition”

Upon request of our Member Prof. Sami Khatib, MTCC contributed to the organization of the 20thPan Arab Cancer Congress by engaging 5 speakers, including MTCC Members

March: MTCC is Collaborating Partner to the HPV Day in collaboration with the IPVS, the “Regina Elena” National Cancer Inst. Rome (HPV Unit chaired by our Member Prof Aldo Venuti) and LILT  by releasing awareness videos and leaflets for the adult and youngsters population

February: MTCC signed a collaboration agreement with the International Papilloma Virus Society (IPVS)

February: on the 25th, the 99th anniversary of the Italian League for the Fight Against Cancer LILT (www.LILT.it), LILT distributes  350 thousand copies of the MTCC primary and secondary prevention leaflets in the Country


On Cancer Day, our Member Dr. Maisam Akaroush gived a Seminar on “Gastro-Intestinal Cancer” at the Patient’s Friends Society Jerusalem chaired by our Member Carol El-Jabari

January: MTCC endorses the Mediterranean Interventional Oncology (Mio–live ) 25-26 January 2021 meeting organized by our Member Prof Roberto Iezzi

Cancer Day 2020

A call for Action by The Mediterranean Taskforce for Cancer Control (MTCC) (www.mtcc-prevention.net)
Increasing the effectiveness of primary and secondary prevention. The Potential role of Military Medical Forces.

Prevention and Early Diagnosis are established priority strategies in cancer control. Therefore, implementation and dissemination of policies aimed at translating these anticipatory care strategies into practice is critical in contrasting the foreseen increasing global cancer burden, changing epidemiology, the diminished role of primary care, costs, and disparities (Theme 2 and 3 World Cancer Congress: Muscat, Oman, Oct 2020)

In peacetime, Military General/Internal medicine and Specialists are engaged in research, development, and care, thus they represent valuable supportive partners of their civilian counterparts in cancer control, primarily in diminishing the incidence of advanced disease, “The key challenge in cancer medicine”

In consideration that Military Medicine

  • is caring for active and retired personnel and their family members in significant number with «no disparities»
  • has a closer logistic and referral (Military Hospitals) between General Medicine and Specialists which is advantageous in limiting the occurrence of «advanced disease»
  • can resort to Opportunistic screenings during the mandatory routine check-up’s
  • features robust command/control hierarchies which can enforce «observance of guidelines»
  • dealing with risk management can manage Environmental /Occupational relevant risks more efficiently
  • is relatively shielded by changes in health care “economic restrictions”

MTCC strongly advocates that Military Medicine merges its defense and security missions with those of civil society at the national and global levels by enforcing the above activities which minimally conflict with the issue of “dual loyalty”.


Early Diagnosis Cancer Day 2019

The  2019 Cancer Day  calls for the need  of  implementing    Early Diagnosis  through  available strategies, thus avoiding  over 3,4 million deaths yearly.  MTCC welcomes this committement which has been advocated  with NO DISCRIMINATIONS  since 2004  founding year .

Rome Febr. 4th, 2019 MIOLive Congress (endorsed by MTCC)

The 4th edition of the Congress (January 28-29) has been particularly rewarding from the scientific point of view and of the increasing (6%) attendance

A total of 305 delegates from 17 Mediterranean Countries attended the MIOLive program

– 25 hours of scientific education

– 4 Honorary Lectures

– 2 Lunch & Learn Symposium

– 3 “Interactive Multidisciplinary Treatment Decision” Sessions for a total of 6 hours of discussion, also reviewing follow-up of cases treated during MIOLive 2018

– 14 live-cases treating both primary and secondary liver tumors.